文献速递心血管技术与安全CT

基于冠周脂肪衰减模型预测无阻塞性冠脉狭窄糖尿病患者的微血管并发症

Prediction of microvascular complications in diabetic patients without obstructive coronary stenosis based on peri-coronary adipose tissue attenuation model.
PubMed 文献 · Eur Radiol · 2022-10-18

本研究回顾性纳入1097例无显著冠脉狭窄的2型糖尿病患者,基于CCTA测量的右冠状动脉冠周脂肪衰减(RCAPCAT)联合临床因素构建预测模型,用于预测糖尿病微血管并发症。结果显示联合模型AUC为0.820,优于仅用临床因素的模型(AUC=0.781,P=0.003),并在内外部验证中表现稳定。

要点

  • RCAPCAT是糖尿病微血管并发症的独立危险因素,可辅助风险分层。
  • 联合临床因素与RCAPCAT的模型预测效能优于纯临床模型(AUC 0.820 vs 0.781)。
  • 该模型在内部和外部验证队列中均表现稳定,适用于无显著冠脉狭窄的糖尿病患者。

核心结论

  • 包含临床因素和RCAPCAT的模型可预测无显著冠脉狭窄糖尿病患者的微血管并发症,且优于仅基于临床因素的模型。

研究设计与样本

  • 训练队列579例,内部验证队列249例,独立外部验证队列269例,总队列1097例。
  • 采用多变量逻辑回归构建模型1(临床因素)和模型2(临床因素+RCAPCAT)。
  • 参考标准为随访期间微血管并发症的发生。

诊断标准与关键数值

  • 模型2在训练队列中AUC=0.820,模型1 AUC=0.781,差异P=0.003。
  • 模型2的Brier分数为0.146,低于模型1的0.164。
  • 模型2准确分类了78.58%的糖尿病微血管并发症患者。
  • 高血压、HbA1c、糖尿病病程和RCAPCAT为独立危险因素。

临床应用与阅片要点

  • 在CCTA报告中可测量RCAPCAT,结合临床因素(高血压、HbA1c、糖尿病病程)辅助识别微血管并发症高危患者。
  • 对于无显著冠脉狭窄的糖尿病患者,RCAPCAT增高提示需关注微血管并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the predictive value of peri-coronary adipose tissue (PCAT) attenuation for microvascular complications in diabetic patients without significant stenosis and to develop a prediction model for early risk stratification.

METHODS: This study retrospectively included patients clinically identified for coronary computed tomography angiography (CCTA) and type 2 diabetes between January 2017 and December 2020. All patients were followed up for at least 1 year. The clinical data and CCTA-based imaging characteristics (including PCAT of major epicardial vessels, high-risk plaque features) were recorded. In the training cohort comprising of 579 patients, two models were developed: model 1 with the inclusion of clinical factors and model 2 incorporating clinical factors + RCAPCAT using multivariable logistic regression analysis. An internal validation cohort comprising 249 patients and an independent external validation cohort of 269 patients were used to validate the proposed models.

RESULTS: Microvascular complications occurred in 69.1% (758/1097) of the current cohort during follow-up. In the training cohort, model 2 exhibited improved predictive power over model 1 based on clinical factors (AUC = 0.820 versus 0.781, p = 0.003) with lower prediction error (Brier score = 0.146 versus 0.164) compared to model 1. Model 2 accurately categorized 78.58% of patients with diabetic microvascular complications. Similar performance of model 2 in the internal validation cohort and the external validation cohort was further confirmed.

CONCLUSIONS: The model incorporating clinical factors and RCAPCAT predicts the development of microvascular complications in diabetic patients without significant coronary stenosis.

KEY POINTS: • Hypertension, HbA1c, duration of diabetes, and RCAPCAT were independent risk factors for microvascular complications. • The prediction model integrating RCAPCAT exhibited improved predictive power over the model only based on clinical factors (AUC = 0.820 versus 0.781, p = 0.003) and showed lower prediction error (Brier score=0.146 versus 0.164).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yu, Ding, Yu, et al. Prediction of microvascular complications in diabetic patients without obstructive coronary stenosis based on peri-coronary adipose tissue attenuation model. Eur Radiol. 2022. PMID: 36255489. doi:10.1007/s00330-022-09176-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。